[Pediatric and adult leukemia with emphasis on chromosome abnormalities and genetic alterations].
Hayashi
Yasuhide
Y
D000328:Adult; D017677:Age Distribution; D017668:Age of Onset; D002648:Child; D002869:Chromosome Aberrations; D050676:Core Binding Factor Alpha 2 Subunit / Q000235:genetics; D020869:Gene Expression Profiling; D016147:Genes, Tumor Suppressor; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D007938:Leukemia / Q000453:epidemiology / Q000235:genetics*; D009154:Mutation; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics; D028861:Nuclear Pore Complex Proteins / Q000235:genetics; D009687:Nuclear Proteins / Q000235:genetics; D000090243:Nucleophosmin; D011505:Protein-Tyrosine Kinases / Q000235:genetics; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics; D051941:fms-Like Tyrosine Kinase 3 / Q000235:genetics
D050676:Core Binding Factor Alpha 2 Subunit; C497422:KMT2A protein, human; D028861:Nuclear Pore Complex Proteins; D009687:Nuclear Proteins; C465451:Nup98 protein, human; C493728:RUNX1 protein, human; D000090243:Nucleophosmin; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase; D011505:Protein-Tyrosine Kinases; D019009:Proto-Oncogene Proteins c-kit; D051941:fms-Like Tyrosine Kinase 3